113 related articles for article (PubMed ID: 8371516)
1. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. II. Interaction with substrate protein.
Ito Y; Onoda Y; Nakamura S; Tagawa K; Fukushima T; Sugawara Y; Takaiti O
Jpn J Pharmacol; 1993 Jun; 62(2):175-81. PubMed ID: 8371516
[TBL] [Abstract][Full Text] [Related]
2. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. I. Inactivation of enzyme protein.
Ito Y; Nakamura S; Onoda Y; Sugawara Y; Takaiti O
Jpn J Pharmacol; 1993 Jun; 62(2):169-74. PubMed ID: 8371515
[TBL] [Abstract][Full Text] [Related]
3. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
Pearson JP; Roberts NB
Clin Sci (Lond); 2001 Apr; 100(4):411-7. PubMed ID: 11256980
[TBL] [Abstract][Full Text] [Related]
4. A kinetic study of protein binding to ecabet sodium using quartz-crystal microbalance.
Kawakami K; Yasuda M; Ishii K; Kokusenya Y; Sato T
Chem Pharm Bull (Tokyo); 1999 Jul; 47(7):919-22. PubMed ID: 10434394
[TBL] [Abstract][Full Text] [Related]
5. Ecabet sodium, a novel locally-acting anti-ulcer agent, protects the integrity of the gastric mucosal gel layer from pepsin-induced disruption in the rat.
Kinoshita M; Endo M; Yasoshima A; Saito N; Yamasaki K; Chishima S; Narita H
Aliment Pharmacol Ther; 1999 May; 13(5):687-94. PubMed ID: 10233194
[TBL] [Abstract][Full Text] [Related]
6. Relationship between gastroprotective effect of locally acting antiulcer agent ecabet sodium and its binding to gastric mucosa in rats. Comparison with sucralfate.
Kinoshita M; Yamasaki K; Kokusenya Y; Tamaki H
Dig Dis Sci; 1995 Mar; 40(3):661-7. PubMed ID: 7895562
[TBL] [Abstract][Full Text] [Related]
7. Effects of ecabet sodium (TA-2711), a new antiulcer agent, on gastrointestinal mucosal prostanoid production and morphology in rats.
Kinoshita M; Iwasaki H; Yasoshima A; Tamaki H
Biol Pharm Bull; 1993 Dec; 16(12):1220-5. PubMed ID: 8130770
[TBL] [Abstract][Full Text] [Related]
8. Effect of a combination of ecabet sodium and cimetidine on experimentally induced gastric lesions and gastric mucosal resistance to ulcerogenic agents in rats.
Kinoshita M; Noto T; Tamaki H
Biol Pharm Bull; 1995 Feb; 18(2):223-6. PubMed ID: 7742788
[TBL] [Abstract][Full Text] [Related]
9. Roles of prostaglandins, nitric oxide and the capsaicin-sensitive sensory nerves in gastroprotection produced by ecabet sodium.
Kinoshita M; Kume E; Tamaki H
J Pharmacol Exp Ther; 1995 Oct; 275(1):494-501. PubMed ID: 7562591
[TBL] [Abstract][Full Text] [Related]
10. Possible mechanism of increase in gastric mucosal PGE2 and PGI2 generation induced by ecabet sodium, a novel gastroprotective agent.
Kinoshita M; Tamaki H
Dig Dis Sci; 1997 Jan; 42(1):83-90. PubMed ID: 9009120
[TBL] [Abstract][Full Text] [Related]
11. Ecabet sodium prevents esophageal lesions induced by the reflux of gastric juice in rats.
Okuyama K; Saito N; Kume E; Noto T; Nagasaki M
Inflammopharmacology; 2007 Apr; 15(2):90-4. PubMed ID: 17450449
[TBL] [Abstract][Full Text] [Related]
12. Effects of ecabet sodium, a novel gastroprotective agent, on mucin metabolism in rat gastric mucosa.
Ichikawa T; Ishihara K; Hayashida H; Hiruma H; Saigenji K; Hotta K
Dig Dis Sci; 2000 Mar; 45(3):606-13. PubMed ID: 10749340
[TBL] [Abstract][Full Text] [Related]
13. Effect of ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells.
Hayashi S; Sugiyama T; Yachi A; Yokota K; Hirai Y; Oguma K; Fujii N
J Gastroenterol; 1997 Oct; 32(5):593-7. PubMed ID: 9349983
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of anti-urease action by the anti-ulcer drug ecabet sodium.
Ito Y; Hongo A; Kinoshita M; Tamaki H
Biol Pharm Bull; 1995 Jun; 18(6):850-3. PubMed ID: 7550119
[TBL] [Abstract][Full Text] [Related]
15. Ecabet sodium, a locally acting antiulcer drug, inhibits urease activity of Helicobacter pylori.
Ito Y; Shibata K; Hongo A; Kinoshita M
Eur J Pharmacol; 1998 Mar; 345(2):193-8. PubMed ID: 9600637
[TBL] [Abstract][Full Text] [Related]
16. Effects of ecabet sodium on experimentally induced reflux esophagitis.
Omura N; Kashiwagi H; Chen G; Yano F; Suzuki Y; Aoki T
J Gastroenterol; 2000; 35(7):504-9. PubMed ID: 10905357
[TBL] [Abstract][Full Text] [Related]
17. Effect of ecabet disodium, a novel locally-acting antiulcer drug, on epithelial restitution following injury by hypertonic NaCl in bullfrog stomach in vitro.
Furukawa O; Kume E; Sugamoto S; Kawauchi S; Takeuchi K
Digestion; 2000; 62(2-3):116-25. PubMed ID: 11025359
[TBL] [Abstract][Full Text] [Related]
18. Effects of the anti-ulcer agents ecabet sodium, cimetidine and sucralfate on acetylsalicylic acid-induced gastric mucosal damage deteriorated by renal failure in rats.
Nogi K; Taniguchi H; Onoda Y
Arzneimittelforschung; 2002; 52(11):828-32. PubMed ID: 12489254
[TBL] [Abstract][Full Text] [Related]
19. Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients.
Shimoyama T; Fukuda Y; Fukuda S; Munakata A; Yoshida Y; Shimoyama T
J Gastroenterol; 1996 Nov; 31 Suppl 9():59-62. PubMed ID: 8959522
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal effect of ecabet sodium on clarithromycin- and metronidazole-resistant clinical isolates of Helicobacter pylori.
Shibata K; Kasuga O; Yasoshima A; Matsushita T; Kawakami Y
Jpn J Antibiot; 1997 Jun; 50(6):525-31. PubMed ID: 9258741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
